Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression

Biological Psychiatry

Volumn 41, Issue 9, 1997, Pages 915-928

  Rush, A John ^a   Giles, Donna E ^b   Schlesser, Michael A ^c   Orsulak, Paul J ^d   Weissenburger, Jan E ^a   Fulton, Carl L ^f   Fairchild, Carol J ^e   Roffwarg, Howard P ^f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Dallas Neuropsychiatry Associates   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f Private Practice   (United States)

Author keywords

bipolar; dexamethasone suppression test nonsuppression; laboratory tests; major depression; REM latency; thyrotropin releasing hormone stimulation test blunting; unipolar

Indexed keywords

DEXAMETHASONE; PROTIRELIN;

ADULT; ARTICLE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REM SLEEP;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; REFERENCE VALUES; SLEEP, REM; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 0030977533     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00148-0     Document Type: Article

References (95)

1. Aggernaes H, Kirkegaard C, Krog-Meyer I, et al (1983): Dexamethasone suppression test and TRH test in endogenous depression. Acta Psychiatr Scand 67:258-264.
2. American Psychiatric Association Task Force on Laboratory Tests in Psychiatry (1987): The dexamethasone suppression test: An overview of its current status in psychiatry. Am J Psychiatry 144:1253-1262.
3. Arana GW, Zarzar, MM, Baker E (1990): The effect of diagnostic methodology on the sensitivity of the TRH stimulation test for depression: A literature review. Biol Psychiatry 28:733-737.
4. Asnis GM, Nathan RS, Halbreich U, Halpern FS, Sachar EJ (1980): TRH test in depression. Lancet 424-425.
5. Baumgartner A, Hahnenkamp L, Meinhold H (1986): Effects of age and diagnosis on thyrotropin response to thyrotropin-releasing hormone in psychiatric patients. Psychiatry Res 17:285-294.
6. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992): Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 49:651-668.
7. Berger M, Doerr P, Lund R, Bronisch T, von Zerssen D (1982): Neuroendocrinological and neurophysiological studies in major depressive disorders: Are there biological markers for the endogenous subtype? Biol Psychiatry 17:1217-1242.
8. Brady KT, Anton RF (1989): The thyroid axis and desipramine treatment in depression. Biol Psychiatry 25:703-709.
9. Brown WA, Shuey I (1980): Response to dexamethasone and subtype of depression. Arch Gen Psychiatry 37:747-751.
10. Buysse DJ, Kupfer DJ (1990): Diagnostic and research applications of electroencephalographic sleep studies in depression. Conceptual and methodological issues. J Nerv Ment Dis 178:405-414.
11. Galloway SP, Dolan RJ, Fonagy P, DeSouza VFA, Wakeling A (1984): Endocrine changes and clinical profiles in depression: I. The dexamethasone suppression test. Psychol Med 14:749-758.
12. Carroll BJ (1982): The dexamethasone suppression test for melancholia. Br J Psychiatry 140:292-304.
13. Carroll BJ, Curtis GC, Mendels J (1976): Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 33:1051-1058.
14. Carroll BJ, Greden JF, Feinberg M, et al (1980): Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. Psychiatry Res 2:251-258.
15. Carroll BJ, Feinberg M, Greden JF, et al (1981): A specific laboratory test for melancholia. Standardization, validation and clinical utility. Arch Gen Psychiatry 38:15-22.
16. Dackis CA, Bailey J, Pottash ALC, Stuckley RF, Extein IL, Gold MS (1984): Specificity of the DST and TRH test for major depression in alcholics. Am J Psychiatry 141:680-683.
17. Davidson J, Lipper S, Zung WWK, Strickland R, Krishnan R, Mahorney S (1984): Validation of four definitions of melancholia by the dexamethasone suppression test. Am J Psychiatry 141:1220-1223.
18. Davis KL, Hollister LE, Mathe AA, et al (1981): Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry 138:1555-1562.
19. Debus JR, Rush AJ (1990): Sleep EEG findings in depression. In McCann CD, Endler NS (eds), Depression: New Directions in Theory, Research and Practice. Toronto: Wall & Emerson, pp 337-360.
20. Endicott J, Spitzer RL (1978): A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
21. Extein I, Pottash ALC, Gold MS (1981): Relationship of thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression. Psychiatry Res 4:49-53.
22. Extein I, Kirstein L, Pottash ALC, Gold MS (1982): The dexamethasone suppression and thyrotropin-releasing hormone tests and response to treatment in unipolar depression. Int J Psychiatry Med 12:267-274.
23. Feinberg M, Gillin JC, Carroll BJ, Greden JF, Zis AP (1982): EEG studies of sleep in the diagnosis of depression. Biol Psychiatry 17:305-316.
24. Fleming JE, Extein I, Sternbach HA, Pottash ALC, Gold MS (1983): The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression. Psychiatry Res 9:53-58.
25. Giles DE, Rush AJ (1982): Relationship of dysfunctional attitudes and dexamethasone response in endogenous and non-endogenous depression. Biol Psychiatry 17:1303-1314.
26. Giles DE, Roffwarg HP, Schlesser MA, Rush AJ (1986): Which endogenous depressive symptoms relate to reduced REM latency? Biol Psychiatry 21:473-482.
27. Giles DE, Schlesser MA, Rush AJ, Orsulak PJ, Fulton CL, Roffwarg HP (1987a): Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: A replication and extension. Biol Psychiatry 22:872-882.
28. Giles DE, Jarrett RB, Roffwarg HP, Rush AJ (1987b): Reduced rapid eye movement latency: A predictor of recurrence in depression. Neuropsychopharmacology 1:33-39.
29. Giles DE, Kupfer DJ, Roffwarg HP, Rush AJ, Biggs MA, Etzel BA (1989): Polysomnographic parameters in first-degree relatives of unipolar probands. Psychiatry Res 27:127-136.
30. Giles DE, Roffwarg HP, Rush AJ, Guzick DS (1990): Age-adjusted threshold values for reduced REM latency in unipolar depression using ROC analysis. Biol Psychiatry 27:841-853.
31. Giles DE, Jarrett RB, Rush AJ, Biggs MM, Roffwarg HP (1993): Prospective assessment of EEG sleep in remitted major depression. Psychiatry Res 46:269-284.
32. Gold MS, Pottash ALC, Extein I, et al (1981): The TRH test in the diagnosis of major and minor depression. Psychoneuroendocrinology 6:159-169.
33. Goodwin FK, Jamison KR (1990): Manic-Depressive Illness. New York: Oxford University Press.
34. Greden JF, de Vigne JP, Albala AA, et al (1982): Serial dexamethasone suppression tests among rapid cycling bipolar patients. Biol Psychiatry 17:455-462.
35. Haggerty JJ Jr, Simon JS, Evans DL, Nemeroff CB (1987): Relationship of serum TSH concentration and antithyroid antibodies to diagnosis and DST response in psychiatric inpatients. Am J Psychiatry 144:1491-1493.
36. Hamilton M (1960): A rating scale for depression. J Neural Neurosurg Psychiatry 23:56-62.
37. Hamilton M (1967): Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
38. Hauri P, Chernik D, Hawkins D, Mendels J (1974): Sleep of depressed patients in remission. Arch Gen Psychiatry 31: 386-391.
39. Holsboer F (1983): Prediction of clinical course by DST response in depressed patients. Physiologic and construct validity of the DST. Pharmacopsychiatria 16:186-191.
40. Hosmer DW, Lemeshow S (1989): Applied Logistic Regression. New York: Wiley.
41. Janowsky DS, Risch SC (1986): Adrenergic-cholinergic balance in affective disorders. In Rush AJ, Altshuler KZ (eds), Depression: Basic Mechanisms, Diagnosis and Treatment. New York: Guilford Press, pp 84-101.
42. Kirkegaard C (1981): The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinology 6:189-212.
43. Kjellman BF, Thorell LH, Orhagen T, d'Elia G, Kagedal B (1993): The hypothalamic-pituitary-thyroid axis in depressive patients and healthy subjects in relation to the hypothalamic-pituitary-adrenal axis. Psychiatry Res 47:7-21.
44. Kumar A, Alcser K, Grunhaus L, Greden JF (1986): Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia. Biol Psychiatry 21:436-444.
45. Kupfer DJ, Reynolds CF III (1992): Sleep and psychiatric disorders. A meta-analysis [comment]. Arch Gen Psychiatry 49:669-670.
46. Kupfer DJ, Thase ME (1983): The use of the sleep laboratory in the diagnosis of affective disorders. Psychiatr Clin North Am 6:3-25.
47. Lamberts SW (1986): Neuro-endocrine aspects of the dexamethasone suppression test in psychiatry. Life Sci 39:91-95.
48. Langer G, Schonbeck G, Kornig G, et al (1980): Evidence for neuroendocrine involvement in the therapeutic effects of antidepressant drugs. In Brambilla F, Racagni G, de Wied D (eds), Progress in Psychoneuroendocrinology. Amsterdam: Elsevier/North-Holland Biomedical Press, pp 197-208.
49. Langer G, Resch F, Aschauer H, et al (1984): TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs. Neuropsychobiology 11:213-218.
50. Loosen PT (1985): The TRH-induced TSH response in psychiatric patients: A possible neuroendocrine marker. Psychoneuroendocrinology 10:237-260.
51. Loosen PT, Prange AJ Jr (1982): Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: A review. Am J Psychiatry 139:405-416.
52. Loosen PT, Prange AJ Jr, Wilson IC, Lara PP, DeHus C (1977): Thyroid stimulating hormone response after thyrotropin releasing hormone in depressed, schizophrenic and normal women. Psychoneuroendocrinology 2:137-148.
53. Macs M, Vandewoude M, Schotte C, Martin M, Blockx P (1990): Suppressive effects of dexamethasone on hypothalamic-pituitary-thyroid axis function in depressed patients. J Affect Disord 20:55-61.
54. Maes M, D'Hondt P, Blockx P, Cosyns P (1994): A further investigation of basal HPT axis function in unipolar depression: Effects of diagnosis, hospitalization, and dexamethasone administration. Psychiatry Res 51:185-201.
55. McCarley RW, Massaquoi SC (1992): Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control. J Sleep Res 1:132-137.
56. Mendlewicz J, Kerkhofs M (1991): Sleep electroencephalography in depressive illness. A collaborative study by the World Health Organization. Br J Psychiatry 159:505-509.
57. Mendlewicz J, Linkowski P, Hoffman G, Kerkhofs M (1983a): Nonsuppression to dexamethasone predicts short REM latency in major depressive illness. Paper presented at the Advances in Sleep Research International Symposium, Brussels, Belgium.
58. Mendlewicz J, Linkowski P, Hoffman G, Kerkhofs M (1983b): Sleep EEC and dexamethasone suppression test. Paper presented at the Belgian Association for the Study of Sleep First International Symposium, Brussels, Belgium.
59. Nierenberg AA, Feinstein AR (1988): How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. JAMA 259:1699-1702.
60. Papakostas Y, Fink M, Lee J, Irwin P, Johnson L (1981): Neuroendocrine measures in psychiatric patients: Course and outcome with ECT. Psychiatry Res 4:55-64.
61. Peselow ED, Goldring N, Fieve RR, Wright R (1983): The dexamethasone suppression test in depressed outpatients and normal control subjects. Am J Psychiatry 140:245-247.
62. Peselow ED, Baxter N, Fieve RR, Barouche F (1987): The dexamethasone suppression test as a monitor of clinical recovery. Am J Psychiatry 144:30-35.
63. Rabkin JG, Quitkin FM, Stewart JR, McGrath PJ, Puig-Antich J (1983): The dexamethasone suppression test with mildly to moderately depressed outpatients. Am J Psychiatry 140:926-927.
64. Rechtschaffen A, Kales A (eds) (1968): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects (National Institute of Health Publication 204). Washington DC: U.S. Government Printing Office.
65. Reichlin S (1974): Neuroendocrinology. In Williams RH (ed), Textbook of Endocrinology, 5th ed. Philadelphia: W.B. Saunders Co, pp 589-645.
66. Reynolds CF III, Kupfer DJ (1987): Sleep research in affective illness: State of the art circa 1987. Sleep 10:199-215.
67. Rubin RT (1989): Pharmacoendocrinology of major depression. Eur Arch Psychiatry Neurol Sci 238:259-267.
68. Rubin RT, Poland RE, Lesser IM, Martin DJ (1987): Neuroendocrine aspects of primary endogenous depression: IV. Pituitary-thyroid axis activity in patients and matched control subjects. Psychoneuroendocrinology 12:333-347.
69. Rupprecht R, Lesch KP (1989): Psychoneuroendocrine research in depression: I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test. J Neural Transm 75:167-178.
70. Rush AJ, Weissenburger JE (1994): Melancholic symptom features and DSM-IV. Am J Psychiatry 51:489-498.
71. Rush AJ, Giles DE, Roffwarg HP, Parker CR Jr (1982a): Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorder. Biol Psychiatry 17:327-341.
72. Rush AJ, Schlesser MA, Giles DE, Crowley GT, Fairchild CJ, Altshuler KZ (1982b): The effect of dosage on the dexamethasone suppression test in normal controls. Psychiatry Res 7:277-285.
73. Rush AJ, Schlesser MA, Roffwarg HP, Giles DE, Orsulak PJ, Fairchild CJ (1983): Relationships among the TRH, REM latency, and dexamethasone suppression tests: Preliminary findings. J. Clin Psychiatry 44:23-29.
74. Rush AJ, Erman MK, Giles DE, et al (1986): Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 43:878-884.
75. Rush AJ, Giles DE, Jarrett RB, et al (1989): Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry 26:61-72.
76. Rush AJ, Cain JW, Raese J, Stewart RS, Waller DA, Debus JR (1991): Neurobiological bases for psychiatric disorders. In Rosenberg RN (ed), Comprehensive Neurology. New York: Raven Press, pp 555-603.
77. Rush AJ, Giles DE, Schlesser MA, et al (1996): The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57:470-484.
78. Schlesser MA, Rush AJ, Orsulak PJ, Crowley GT (1983a): Serial measurement of hypothalamic-pituitary-adrenal axis in rapid cycling bipolar subjects. Poster presented at the World Congress of Psychiatry, Vienna, Austria.
79. Schlesser MA, Rush AJ, Fairchild CJ, Crowley GT, Orsulak PJ (1983b): Thyrotropin-releasing hormone test: A methodological study. Psychiatry Res 9:59-67.
80. Schlesser MA, Fulton CL, Orsulak PJ, Fairchild CJ, Rush AJ (1985): TRH stimulation test in normal male and female subjects: Methodological considerations. Paper presented at the IVth World Congress of Biological Psychiatry, Philadelphia, Pennsylvania.
81. Schulz H, Trogan B (1979): A comparison of eye movement density in normal subjects and in depressed patients before and after remission. Sleep Res 8:49.
82. Spitzer RL, Endicott J (1977): Schedule for Affective Disorders and Schizophrenia (SADS), 3rd ed. New York: New York State Psychiatric Institute, Biometrics Research Department.
83. Spitzer RL, Endicott J, Robins E (1978): Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 36: 773-782.
84. Steiger A, von Bardeleben U, Wiedemann K, Holsboer F (1991): Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J Psychiatr Res 25:169-177.
85. Stokes PE (1988): Psychoendocrinology of depression and mania. In Georgatas A, Cancro R (eds), Depression and Mania. New York: Elsevier, pp 290-304.
86. Stokes PE, Stoll PM, Koslow SH, et al (1984): Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Arch Gen Psychiatry 41:257-267.
87. Targum SD (1983): The application of serial neuroendocrine challenge studies in the management of depressive disorder. Biol Psychiatry 18:3-19.
88. Targum S, Byrnes S, Sullivan A (1982a): The TRH stimulation test in subtypes of unipolar depression. J Affect Disord 4:29-34.
89. Targum SD, Sullivan C, Byrnes SM (1982b): Neuroendocrine interrelationships in major depressive disorder. Am J Psychiatry 139:282-286.
90. von Bardeleben U, Holsboer F (1988): Human corticotropin releasing hormone: Clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls. Prog Neuropsychopharmacol Biol Psychiatry 12(suppl): S165-S187.
91. Wiedemann K, Lauer C, Pollmacher T, Holsboer F (1994): Sleep endocrine effects of antigluco-and antimineralocorticoids in healthy males. Am J Physiol 267:E109-E114.
92. Winokur A, Amsterdam JD, Caroff S, Snyder PJ, Brunswick D (1982): Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients. Am J Psychiatry 139:39-44.
93. Winokur A, Amsterdam JD, Oler J, et al (1983a): Multiple hormonal responses to protirelin (TRH) in depressed patients. Arch Gen Psychiatry 40:525-531.
94. Winokur A, Amsterdam JD, Caroff SN (1983b): Neuroendocrine responses in endogenous and nonendogenous depressed patients. Paper presented at the Society of Biological Psychiatry, New York, New York.
95. Zimmerman M, Coryell WH, Pfohl B, Stangl D (1985): Four definitions of endogenous depression and the dexamethasone suppression test. J Affect Disord 8:37-45.